BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh S, Khan A. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study. Gastroenterology. 2020;159:768-771.e3. [PMID: 32376408 DOI: 10.1053/j.gastro.2020.04.064] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 47.5] [Reference Citation Analysis]
Number Citing Articles
1 Qu J, Sumali B, Lee H, Terai H, Ishii M, Fukunaga K, Mitsukura Y, Nishimura T. Finding of the factors affecting the severity of COVID-19 based on mathematical models. Sci Rep 2021;11:24224. [PMID: 34930966 DOI: 10.1038/s41598-021-03632-x] [Reference Citation Analysis]
2 Ekpanyapong S, Bunchorntavakul C, Reddy KR. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. J Viral Hepat 2021. [PMID: 34352133 DOI: 10.1111/jvh.13590] [Reference Citation Analysis]
3 Przekop D, Gruszewska E, Chrostek L. Liver function in COVID-19 infection . World J Hepatol 2021; 13(12): 1909-1918 [DOI: 10.4254/wjh.v13.i12.1909] [Reference Citation Analysis]
4 Pasha SB, Swi A, Hammoud GM. Gastrointestinal and hepatic manifestations of COVID-19 infection: Lessons for practitioners. World J Meta-Anal 2020; 8(5): 348-374 [DOI: 10.13105/wjma.v8.i5.348] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Liaquat H, Shupp B, Rollins S, Schneider Y, Matin A. Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease. Sci Rep 2021;11:19245. [PMID: 34584170 DOI: 10.1038/s41598-021-98778-z] [Reference Citation Analysis]
6 Baroiu L, Dumitru C, Iancu A, Leșe AC, Drăgănescu M, Baroiu N, Anghel L. COVID-19 impact on the liver. World J Clin Cases 2021; 9(16): 3814-3825 [PMID: 34141738 DOI: 10.12998/wjcc.v9.i16.3814] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 An Y, Ma Z, Guo X, Tang Y, Meng H, Yu H, Peng C, Chu G, Wang X, Teng Y, Zhang Q, Zhu T, Wang B, Tong Z, Zhao H, Lu H, Qi X. Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study. Medicine (Baltimore) 2021;100:e25497. [PMID: 34106589 DOI: 10.1097/MD.0000000000025497] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ferrari F, Martins VM, Fuchs FD, Stein R. Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review. Clinics (Sao Paulo) 2021;76:e2342. [PMID: 33852652 DOI: 10.6061/clinics/2021/e2342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21:5254. [PMID: 32722100 DOI: 10.3390/ijms21155254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
11 Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, Zhao K, Ouyang S. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021;18:121. [PMID: 34108015 DOI: 10.1186/s12985-021-01593-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Syed A, Khan A, Gosai F, Asif A, Dhillon S. Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. J Community Hosp Intern Med Perspect. 2020;10:523-528. [PMID: 33194122 DOI: 10.1080/20009666.2020.1811556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Attauabi M, Burisch J, Bendtsen F, Kimer N. A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019. Scand J Gastroenterol 2021;56:453-7. [PMID: 33590789 DOI: 10.1080/00365521.2021.1881814] [Reference Citation Analysis]
14 Yang HY, Jin B, Mao YL. Liver injury in COVID-19: What do we know now? Hepatobiliary Pancreat Dis Int. 2020;19:407-408. [PMID: 32753332 DOI: 10.1016/j.hbpd.2020.07.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Marasco G, Lenti MV, Cremon C, Barbaro MR, Stanghellini V, Di Sabatino A, Barbara G. Implications of SARS-CoV-2 infection for neurogastroenterology.Neurogastroenterol Motil. 2021;33:e14104. [PMID: 33591607 DOI: 10.1111/nmo.14104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 Zhu J, Wei Z, Suryavanshi M, Chen X, Xia Q, Jiang J, Ayodele O, Bradbury BD, Brooks C, Brown CA, Cheng A, Critchlow CW, Devercelli G, Gandhi V, Gondek K, Londhe AA, Ma J, Jonsson-Funk M, Keenan HA, Manne S, Ren K, Sanders L, Yu P, Zhang J, Zhou L, Bao Y. Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study. BMJ Open 2021;11:e051588. [PMID: 34362806 DOI: 10.1136/bmjopen-2021-051588] [Reference Citation Analysis]
17 Lee A, Wein AN, Doyle MBM, Chapman WC. Liver transplantation for post-COVID-19 sclerosing cholangitis. BMJ Case Rep 2021;14:e244168. [PMID: 34446515 DOI: 10.1136/bcr-2021-244168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Aleem A, Mahadevaiah G, Shariff N, Kothadia JP. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness. Proc (Bayl Univ Med Cent) 2021;34:473-7. [PMID: 34219928 DOI: 10.1080/08998280.2021.1885289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Pakhchanian H, Raiker R, Mukherjee A, Khan A, Singh S, Chatterjee A. Outcomes of COVID-19 in CKD Patients: A Multicenter Electronic Medical Record Cohort Study. Clin J Am Soc Nephrol 2021;16:785-6. [PMID: 33558255 DOI: 10.2215/CJN.13820820] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
20 Lin J, Bao B, Khurram NA, Halsey K, Choi JW, Wang L, Tran TML, Liao WH, Feldman MD, Zhang PJ, Wu J, Bai HX. Chronic liver disease not a significant comorbid condition for COVID-19. Sci Rep 2021;11:11734. [PMID: 34083670 DOI: 10.1038/s41598-021-91238-8] [Reference Citation Analysis]
21 Artru F, Alberio L, Moradpour D, Stalder G. Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis. BMJ Case Rep 2020;13:e236815. [PMID: 32641442 DOI: 10.1136/bcr-2020-236815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
22 Xiang F, Sun J, Chen PH, Han P, Zheng H, Cai S, Kirk GD. Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019. Clin Infect Dis 2021;73:e594-601. [PMID: 33909004 DOI: 10.1093/cid/ciaa1710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Middleton P, Hsu C, Lythgoe MP. Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies. BMJ Open Gastroenterol 2021;8:e000739. [PMID: 34675033 DOI: 10.1136/bmjgast-2021-000739] [Reference Citation Analysis]
24 Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, Soza A, Graham R, Riquelme A, Arrese M, Leise MD, Arab JP. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol 2020; 26(48): 7693-7706 [PMID: 33505145 DOI: 10.3748/wjg.v26.i48.7693] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
25 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
26 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, Pose E, Brenner EJ, Cargill T, Catana MA, Dhanasekaran R, Eshraghian A, García-Juárez I, Gill US, Jones PD, Kennedy J, Marshall A, Matthews C, Mells G, Mercer C, Perumalswami PV, Avitabile E, Qi X, Su F, Ufere NN, Wong YJ, Zheng MH, Barnes E, Barritt AS 4th, Webb GJ. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol 2021;74:567-77. [PMID: 33035628 DOI: 10.1016/j.jhep.2020.09.024] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 34.5] [Reference Citation Analysis]
28 Ishigaki H, Nakayama M, Kitagawa Y, Nguyen CT, Hayashi K, Shiohara M, Gotoh B, Itoh Y. Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques. Virology 2021;554:97-105. [PMID: 33412411 DOI: 10.1016/j.virol.2020.12.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 Bender JM, Worman HJ. Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City. J Clin Transl Hepatol 2021;9:551-8. [PMID: 34447685 DOI: 10.14218/JCTH.2020.00171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mallet V, Beeker N, Bouam S, Sogni P, Pol S; Demosthenes research group. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020. J Hepatol 2021;75:848-55. [PMID: 33992699 DOI: 10.1016/j.jhep.2021.04.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Ponziani FR, Nesci A, Del Zompo F, Santopaolo F, Pompili M, Gasbarrini A. Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection. Gastroenterology 2021;160:1891-3. [PMID: 33387522 DOI: 10.1053/j.gastro.2020.05.103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Su F. COVID-19 and Cirrhosis: A Combination We Must Strive to Prevent. Gastroenterology 2021;161:1371-3. [PMID: 34453892 DOI: 10.1053/j.gastro.2021.08.037] [Reference Citation Analysis]
33 Ge J, Pletcher MJ, Lai JC; N3C Consortium. Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study. medRxiv 2021:2021. [PMID: 34127981 DOI: 10.1101/2021.06.03.21258312] [Reference Citation Analysis]
34 Campos-Varela I, Villagrasa A, Simon-Talero M, Riveiro-Barciela M, Ventura-Cots M, Aguilera-Castro L, Alvarez-Lopez P, Nordahl EA, Anton A, Bañares J, Barber C, Barreira-Diaz A, Biagetti B, Camps-Relats L, Ciudin A, Cocera R, Dopazo C, Fernandez A, Jimenez C, Jimenez MM, Jofra M, Gil C, Gomez-Gavara C, Guanozzi D, Guevara JA, Lobo B, Malagelada C, Martinez-Camprecios J, Mayorga L, Miret E, Pando E, Pérez-Lopez A, Pigrau M, Prio A, Rivera-Esteban JM, Romero A, Tasayco S, Vidal-Gonzalez J, Vidal L, Minguez B, Augustin S, Genesca J. The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19. Therap Adv Gastroenterol 2021;14:17562848211016567. [PMID: 34104210 DOI: 10.1177/17562848211016567] [Reference Citation Analysis]
35 Saviano A, Wrensch F, Ghany MG, Baumert TF. Liver disease and COVID-19: from Pathogenesis to Clinical Care. Hepatology. 2020;. [PMID: 33332624 DOI: 10.1002/hep.31684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
36 Łykowska-Szuber L, Wołodźko K, Rychter AM, Szymczak-Tomczak A, Krela-Kaźmierczak I, Dobrowolska A. Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review. J Clin Med 2021;10:5048. [PMID: 34768568 DOI: 10.3390/jcm10215048] [Reference Citation Analysis]
37 Cao TT, Zhang GQ, Pellegrini E, Zhao Q, Li J, Luo LJ, Pan HQ. COVID-19 and its effects on the digestive system. World J Gastroenterol 2021; 27(24): 3502-3515 [PMID: 34239265 DOI: 10.3748/wjg.v27.i24.3502] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Lizardo-thiebaud MJ, Cervantes-alvarez E, Limon-de la Rosa N, Tejeda-dominguez F, Palacios-jimenez M, Méndez-guerrero O, Delaye-martinez M, Rodriguez-alvarez F, Romero-morales B, Liu W, Huang CA, Kershenobich D, Navarro-alvarez N. Direct or Collateral Liver Damage in SARS-CoV-2–Infected Patients. Semin Liver Dis 2020;40:321-30. [DOI: 10.1055/s-0040-1715108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
39 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Reference Citation Analysis]
40 Singh S, Khan A, Chowdhry M, Bilal M, Kochhar GS, Clarke K. Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study. Gastroenterology. 2020;159:1575-1578.e4. [PMID: 32522507 DOI: 10.1053/j.gastro.2020.06.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
41 Jeon D, Son M, Choi J. Impact of Liver Cirrhosis on the Clinical Outcomes of Patients with COVID-19: A Nationwide Cohort Study of Korea. Korean J Intern Med. [DOI: 10.3904/kjim.2020.486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Choudhary NS, Dhampalwar S, Saraf N, Soin AS. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. J Clin Exp Hepatol 2021. [PMID: 33994708 DOI: 10.1016/j.jceh.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Cococcia S, Lenti MV, Santacroce G, Achilli G, Borrelli de Andreis F, Di Sabatino A. Liver-spleen axis dysfunction in COVID-19. World J Gastroenterol 2021; 27(35): 5919-5931 [PMID: 34629809 DOI: 10.3748/wjg.v27.i35.5919] [Reference Citation Analysis]
44 Chela HK, Pasha SB, Basar O, Daglilar E, Tahan V. Liver in the limelight in the corona (COVID-19) time. World J Clin Cases 2020; 8(16): 3405-3410 [PMID: 32913847 DOI: 10.12998/wjcc.v8.i16.3405] [Reference Citation Analysis]
45 Ramkissoon R, Wang XJ. The Impact of COVID-19 in Gastroenterology and Hepatology. J Clin Gastroenterol 2021;55:757-65. [PMID: 34420001 DOI: 10.1097/MCG.0000000000001600] [Reference Citation Analysis]
46 Lv Y, Zhao X, Wang Y, Zhu J, Ma C, Feng X, Ma Y, Zheng Y, Yang L, Han G, Xie H. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19. Front Med (Lausanne) 2021;8:639855. [PMID: 34179034 DOI: 10.3389/fmed.2021.639855] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Wiener RC. Unhealthy Opioid Use and COVID-19 Mortality Incidence in Older Adults: A Multicenter Research Network Study. Subst Use Misuse 2021;56:2044-8. [PMID: 34429022 DOI: 10.1080/10826084.2021.1967988] [Reference Citation Analysis]
48 Wang Q, Davis PB, Xu R. COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States. EClinicalMedicine. 2021;31:100688. [PMID: 33521611 DOI: 10.1016/j.eclinm.2020.100688] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
49 Song JE, Kang MK, Lee YR, Lee CH, Park JG, Kweon YO, Tak WY, Park SY, Jang SY, Hwang JS, Jang BK, Jang WY, Suh JI, Chung WJ, Kim BS; Daegu-Gyeongbuk Liver Study Group (DGLSG). Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment. Gut Liver 2021;15:606-15. [PMID: 33782216 DOI: 10.5009/gnl20267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Galiero R, Pafundi PC, Simeon V, Rinaldi L, Perrella A, Vetrano E, Caturano A, Alfano M, Beccia D, Nevola R, Marfella R, Sardu C, Coppola C, Scarano F, Maggi P, De Lucia Sposito P, Vocciante L, Rescigno C, Sbreglia C, Fraganza F, Parrella R, Romano A, Calabria G, Polverino B, Pagano A, Bologna C, Amitrano M, Esposito V, Coppola N, Maturo N, Adinolfi LE, Chiodini P, Sasso FC; COVOCA Study Group. Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study. PLoS One 2020;15:e0243700. [PMID: 33301529 DOI: 10.1371/journal.pone.0243700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
51 Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, Liu MQ, Wei L, Nasser MI, Xu LY, Zhu P, Zhao MY. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed Pharmacother 2021;133:111064. [PMID: 33378966 DOI: 10.1016/j.biopha.2020.111064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
52 Verma N, Duseja A, Singh V. Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease. Gastroenterology. 2021;160:1893-1894. [PMID: 32553766 DOI: 10.1053/j.gastro.2020.05.090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
54 Koppe U, Wilking H, Harder T, Haas W, Rexroth U, Hamouda O. [COVID-19 patients in Germany: exposure risks and associated factors for hospitalization and severe disease]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021;64:1107-15. [PMID: 34327540 DOI: 10.1007/s00103-021-03391-0] [Reference Citation Analysis]
55 Yoo HW, Jin HY, Yon DK, Effenberger M, Shin YH, Kim SY, Yang JM, Kim MS, Koyanagi A, Jacob L, Smith L, Yoo IK, Shin JI, Lee SW. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort. J Korean Med Sci 2021;36:e291. [PMID: 34697932 DOI: 10.3346/jkms.2021.36.e291] [Reference Citation Analysis]
56 Wang T, Smith DA, Campbell C, Harris S, Salih H, Várnai KA, Woods K, Noble T, Freeman O, Moysova Z, Marjot T, Webb GJ, Davies J, Barnes E, Matthews PC. Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers. Hepatol Commun 2021. [PMID: 34222741 DOI: 10.1002/hep4.1739] [Reference Citation Analysis]
57 Fang LG, Zhou Q. Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overview. World J Clin Cases 2021; 9(19): 4969-4979 [PMID: 34307547 DOI: 10.12998/wjcc.v9.i19.4969] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Altaf A, Abbas Z, Mandviwalla HA, Qadeer MA, Siyal M, Tariq M, Ghafoor A, Karamat M, Shahid B, Ali M. Severe COVID-19 Associated With Liver Injury in Patients Without Preexisting Liver Disease. Cureus. 2021;13:e14705. [PMID: 34055545 DOI: 10.7759/cureus.14705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Reference Citation Analysis]
60 Herta T, Berg T. COVID-19 and the liver - Lessons learned. Liver Int. 2021;41 Suppl 1:1-8. [PMID: 34155789 DOI: 10.1111/liv.14854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Berry SK, Fontana RJ. Potential Treatments for SARS-CoV-2 Infection. Clin Liver Dis (Hoboken) 2020;15:181-6. [PMID: 32537133 DOI: 10.1002/cld.969] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Boraschi P, Giugliano L, Mercogliano G, Donati F, Romano S, Neri E. Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful? World J Gastroenterol 2021; 27(26): 4143-4159 [PMID: 34326615 DOI: 10.3748/wjg.v27.i26.4143] [Reference Citation Analysis]
63 Rosenblatt R, Verna EC. COVID 19: Management of Decompensated Cirrhosis and Liver Transplant Recipients. Clin Liver Dis (Hoboken). 2020;15:200-203. [PMID: 32537136 DOI: 10.1002/cld.968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
64 Rios RS, Zheng KI, Zheng MH. Data sharing during COVID-19 pandemic: what to take away. Expert Rev Gastroenterol Hepatol 2020;14:1125-30. [PMID: 32842793 DOI: 10.1080/17474124.2020.1815533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
65 Xu W, Huang C, Fei L, Li Q, Chen L. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study. Clin Interv Aging 2021;16:675-85. [PMID: 33911856 DOI: 10.2147/CIA.S303629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Belli LS, Duvoux C, Cortesi PA, Facchetti R, Iacob S, Perricone G, Radenne S, Conti S, Patrono D, Berlakovich G, Hann A, Pasulo L, Castells L, Faitot F, Detry O, Invernizzi F, Magini G, De Simone P, Kounis I, Morelli MC, Díaz Fontenla F, Ericzon BG, Loinaz C, Johnston C, Gheorghe L, Lesurtel M, Romagnoli R, Kollmann D, Perera MTP, Fagiuoli S, Mirza D, Coilly A, Toso C, Zieniewicz K, Elkrief L, Karam V, Adam R, den Hoed C, Merli M, Puoti M, De Carlis L, Oniscu GC, Piano S, Angeli P, Fondevila C, Polak WG; for all the centres contributing to the ELITA-ELTR COVID-19 Registry. COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study. Gut 2021:gutjnl-2021-324879. [PMID: 34281984 DOI: 10.1136/gutjnl-2021-324879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55. [PMID: 33185910 DOI: 10.1111/all.14657] [Cited by in Crossref: 35] [Cited by in F6Publishing: 54] [Article Influence: 17.5] [Reference Citation Analysis]
68 Ioannou GN, Liang PS, Locke E, Green P, Berry K, O'Hare AM, Shah JA, Crothers K, Eastment MC, Fan VS, Dominitz JA. Cirrhosis and Severe Acute Respiratory Syndrome Coronavirus 2 Infection in US Veterans: Risk of Infection, Hospitalization, Ventilation, and Mortality. Hepatology 2021;74:322-35. [PMID: 33219546 DOI: 10.1002/hep.31649] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
69 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
70 Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GYH. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLoS Med. 2020;17:e1003321. [PMID: 32911500 DOI: 10.1371/journal.pmed.1003321] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 52.5] [Reference Citation Analysis]
71 Merino J, Joshi AD, Nguyen LH, Leeming ER, Mazidi M, Drew DA, Gibson R, Graham MS, Lo CH, Capdevila J, Murray B, Hu C, Selvachandran S, Hammers A, Bhupathiraju SN, Sharma SV, Sudre C, Astley CM, Chavarro JE, Kwon S, Ma W, Menni C, Willett WC, Ourselin S, Steves CJ, Wolf J, Franks PW, Spector TD, Berry S, Chan AT. Diet quality and risk and severity of COVID-19: a prospective cohort study. Gut 2021;70:2096-104. [PMID: 34489306 DOI: 10.1136/gutjnl-2021-325353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
72 Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases 2021; 9(3): 528-539 [PMID: 33553391 DOI: 10.12998/wjcc.v9.i3.528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
73 Mollalo A, Rivera KM, Vahabi N. Spatial statistical analysis of pre-existing mortalities of 20 diseases with COVID-19 mortalities in the continental United States. Sustain Cities Soc 2021;67:102738. [PMID: 33532175 DOI: 10.1016/j.scs.2021.102738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Liu X, Li X, Sun T, Qin H, Zhou Y, Zou C, Cao J, Zhang H. East-West differences in clinical manifestations of COVID-19 patients: A systematic literature review and meta-analysis. J Med Virol 2021;93:2683-93. [PMID: 33325107 DOI: 10.1002/jmv.26737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
75 Frager SZ, Szymanski J, Schwartz JM, Massoumi HS, Kinkhabwala M, Wolkoff AW. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis. Hepatol Commun. 2020;5:424-433. [PMID: 33681677 DOI: 10.1002/hep4.1648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
76 Oikonomou KG, Papamichalis P, Zafeiridis T, Xanthoudaki M, Papapostolou E, Valsamaki A, Bouliaris K, Papamichalis M, Karvouniaris M, Vlachostergios PJ, Skoura AL, Komnos A. Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions. World J Clin Cases 2021; 9(19): 4918-4938 [PMID: 34307544 DOI: 10.12998/wjcc.v9.i19.4918] [Reference Citation Analysis]
77 Ali N. Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data. Front Med (Lausanne) 2020;7:458. [PMID: 32793619 DOI: 10.3389/fmed.2020.00458] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
78 Xian H, Liu Y, Rundberg Nilsson A, Gatchalian R, Crother TR, Tourtellotte WG, Zhang Y, Aleman-Muench GR, Lewis G, Chen W, Kang S, Luevanos M, Trudler D, Lipton SA, Soroosh P, Teijaro J, de la Torre JC, Arditi M, Karin M, Sanchez-Lopez E. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 2021;54:1463-1477.e11. [PMID: 34115964 DOI: 10.1016/j.immuni.2021.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
79 Parcha V, Kalra R, Glenn AM, Davies JE, Kuranz S, Arora G, Arora P. Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic. JTCVS Open 2021;6:132-43. [PMID: 33870234 DOI: 10.1016/j.xjon.2021.03.016] [Reference Citation Analysis]
80 D'Amora P, Silva IDCG, Budib MA, Ayache R, Silva RMS, Silva FC, Appel RM, Júnior SS, Pontes HBD, Alvarenga AC, Arima EC, Martins WG, Silva NLF, Diaz RS, Salzgeber MB, Palma AM, Evans SS, Nagourney RA. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection. PLoS One 2021;16:e0259909. [PMID: 34851990 DOI: 10.1371/journal.pone.0259909] [Reference Citation Analysis]
81 Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. J Clin Transl Hepatol 2021;9:239-46. [PMID: 34007806 DOI: 10.14218/JCTH.2020.00126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
83 Moreira JLS, Barbosa SMS, Gonçalves Júnior J. Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review. Clin Res Hepatol Gastroenterol 2021;45:101752. [PMID: 34303828 DOI: 10.1016/j.clinre.2021.101752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
85 Saithanyamurthi HV, Munirathinam M, Ananthavadivelu M. Prevalence of liver injury in 445 patients with Corona Virus Disease-19-Single-centre experience from southern India. Indian J Gastroenterol 2021;40:303-8. [PMID: 33991309 DOI: 10.1007/s12664-021-01147-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Romero-Cristóbal M, Clemente-Sánchez A, Piñeiro P, Cedeño J, Rayón L, Del Río J, Ramos C, Hernández DA, Cova M, Caballero A, Garutti I, García-Olivares P, Hortal J, Guerrero JE, García R, Bañares R, Rincón D. Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients. Therap Adv Gastroenterol 2021;14:17562848211023410. [PMID: 34178116 DOI: 10.1177/17562848211023410] [Reference Citation Analysis]
87 Taylor R 3rd, Mallon D. COVID-19 and Pediatric Gastroenterology. Pediatr Clin North Am 2021;68:1157-69. [PMID: 34736582 DOI: 10.1016/j.pcl.2021.07.003] [Reference Citation Analysis]
88 Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Demirtas CO, Keklikkiran C, Ergenc I, Erturk Sengel B, Eskidemir G, Cinel I, Odabasi Z, Korten V, Yilmaz Y. Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study. Int J Clin Pract 2021;75:e14363. [PMID: 33993597 DOI: 10.1111/ijcp.14363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen V, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin K, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch A, Viveiros K, Chan W, Chascsa D, Kwo P, Dhanasekaran R. Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2020;. [PMID: 32950749 DOI: 10.1016/j.cgh.2020.09.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
91 Cabibbo G, Rizzo GEM, Stornello C, Craxì A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepat 2021;28:4-11. [PMID: 33190321 DOI: 10.1111/jvh.13440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
92 Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int. 2020;14:612-620. [PMID: 32725453 DOI: 10.1007/s12072-020-10078-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
93 Parcha V, Booker KS, Kalra R, Kuranz S, Berra L, Arora G, Arora P. A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States. Sci Rep 2021;11:10231. [PMID: 33986390 DOI: 10.1038/s41598-021-89553-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
94 Sarkar S, Taylor A, Dutta P, Bajaj M, Nash J, Ravola M, Ievleva S, Llyod C, Ola P, Jenkins B, Sengupta B, Roy D. Health disparity and COVID-19-A retrospective analysis. Health Sci Rep 2021;4:e345. [PMID: 34386613 DOI: 10.1002/hsr2.345] [Reference Citation Analysis]
95 Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl 2021;27:1312-25. [PMID: 34096188 DOI: 10.1002/lt.26194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in Children With Liver Disease. Front Pediatr 2021;9:616381. [PMID: 33777864 DOI: 10.3389/fped.2021.616381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH. Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline. Clin Mol Hepatol 2021;27:515-23. [PMID: 34530524 DOI: 10.3350/cmh.2021.0293] [Reference Citation Analysis]
98 Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, Koch J, Nygren T, Scholz S, Schönfeld V, Vygen-Bonnet S, Wichmann O, Harder T. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med 2021;19:212. [PMID: 34446016 DOI: 10.1186/s12916-021-02058-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
99 Afify S, Eysa B, Hamid FA, Abo-Elazm OM, Edris MA, Maher R, Abdelhalim A, Abdel Ghaffar MM, Omran DA, Shousha HI. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 2021; 27(42): 7362-7375 [PMID: 34876795 DOI: 10.3748/wjg.v27.i42.7362] [Reference Citation Analysis]
100 Ge J, Pletcher MJ, Lai JC; N3C Consortium. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study. Gastroenterology 2021:S0016-5085(21)03244-3. [PMID: 34284037 DOI: 10.1053/j.gastro.2021.07.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233 [PMID: 34786163 DOI: 10.4254/wjh.v13.i10.1215] [Reference Citation Analysis]
102 Patel P, Pillai A. Liver Transplantation Services During the Time of COVID-19. J Clin Transl Hepatol 2021;9:587-91. [PMID: 34447689 DOI: 10.14218/JCTH.2021.00095] [Reference Citation Analysis]
103 Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, Yllescas M, Arriba JR; COVID-19@Spain Study Group., Fundación SEIMC-GESIDA., Hospital General Universitario Gregorio Marañón., Hospital Universitario La Paz., Hospital Infanta Leonor., Complejo Hospitalario Virgen de la Salud., Hospital Universitario Rafael Méndez., Hospital Universitario de Cruces., Hospital de Melilla., Hospital San Eloy de Barakaldo., Hospital Universitario Central de Asturias., Hospital General Universitario de Alicante., Hospital Virgen de la Victoria., Hospital Universitario Puerto Real., EOXI Pontevedra e Salnés., Hospital de Figueres., Hospital Sant Jaume de Calella., Hospital del Mar., Hospital Virgen de la Arrixaca., Hospital de Can Misses., Hospital de Sagunto., Hospital Clínico San Cecilio., Hospital Universitario Príncipe de Asturias., Parc Sanitari Sant Joan de Déu., Hospital Nuestra Señora de Gracia., HC Marbella Internacional Hospital., Hospital La Princesa., Hospital Josep Trueta., Hospital Dos de Maig., Hospital Arnau de Vilanova-Lliria., Hospital General Universitario de Elche., Hospital Clínico Universitario de Valencia., Complejo Asistencial de Ávila., Hospital Comarcal de Alcañiz., Hospital Universitario Marqués de Valdecilla., Hospital Quiron-Salud de Torrevieja., Hospital Universitario Miguel Servet., SCIAS, Hospital de Barcelona., Fundación Hospital Universitario Alcorcón., Hospital Álvaro Cunqueiro., Complejo Asistencial Universitario de Salamanca., Hospital Universitario Severo Ochoa., Hospital CIMA-Sanitas., Hospital HLA Inmaculada., Hospital Universitario Rio Hortega., Hospital de Guadalajara., Hospital Universitario Infanta Sofía., Hospital Comarcal de Blanes., Hospital Universitari de Tarragona Joan XXIII., Hospital Universitario Basurto., Hospital Universitario de Canarias., Hospital Universitario de Gran Canaria Dr Negrín., Hospital Son Espases., Hospital Universitario de Móstoles., Complejo Hospitalario Universitario A Coruña., Hospital Costa del Sol., Hospital Clínico Universitario Lozano Blesa., Hospital Mutua de Terrassa., Hospital de la Plana., Hospital Virgen de la Concha–Complejo Asistencial de Zamora., Complejo Hospitalario Universitario Insular Materno-Infantil., Hospital de la Marina Baixa., Hospital Universitario Virgen Macarena., Hospital Universitari de Bellvitge., Hospital Universitario y Politécnico la Fe., Hospital Universitario del Vinalopó., Hospital de Sabadell (Parc Tauli)., Hospital Clinic de Barcelona., Hospital Universitario de la Ribera., Fundación Jiménez Díaz., Hospital Clínico Universitario de Valladolid., Hospital Clínico San Carlos., Hospital Santa Creu i Sant Pau., Clínica Universitaria de Navarra–Campus Madrid., Hospital Son Llatzer., Hospital General de la Defensa Gómez Ulla., Hospital Universitario de Álava., Hospital Santos Reyes., Hospital Dr José Molina Orosa., Hospital Vall d’Hebrón., Hospital Universitario Rey Juan Carlos., Complejo Hospitalario Universitario Santa Lucía., Hospital Santa Bárbara., Complejo Hospitalario Universitario de Ferrol., Hospital de l'Esperit Sant., Hospital Universitario los Arcos del Mar Menor., Hospital HLA Universitario Moncloa., Hospital Virgen del Puerto., Hospital Marina Salud de Dénia., Hospital Universitario de Jerez., Hospital Reina Sofía de Tudela., Hospital Clínico Universitario de Santiago de Compostela., Hospital Universitario del Henares., Hospital Universitario Lucus Augusti., Hospital de Donostia., Hospital de Urduliz Alfredo Espinosa., Hospital de Mendaro., Hospital Juan Ramón Jiménez., Hospital de Tortosa Virgen de la Cinta., Hospital Riotinto., Hospital Vega Baja., Hospital Puerta de Hierro., Hospital Universitario de Getafe., Hospital General de la Palma., Hospital El Bierzo., Fundación Hospital de Calahorra., Hospital Alto Deba., Hospital Universitario San Juan de Alicante., Hospital de Guadarrama., Hospital Universitario de Jaén., Hospital de Mataró., Hospital de Palamós., Hospital Universitario de Valme., Clínica Universitaria de Navarra–Campus Navarra., Hospital Clínica Benidorm., Hospital Doce de Octubre., Hospital Universitario Virgen del Rocío., Hospital Universitario Ramón y Cajal., Hospital Universitario San Pedro., Hospital Quirón A Coruña., HM Sanchinarro., Hospital Francesc de Borja., Complejo Hospitalario Universitario Nuestra Señora de La Candelaria., Hospital Universitario HM Montepríncipe., Hospital Universitario HM Puerta del Sur., Hospital Universitario HM Torrelodones., Hospital Universitario HM Madrid., Hospital Don Benito-Villanueva de la Serena., Hospital de Viladecans., Centro Nacional de Epidemiología. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect 2020;26:1525-36. [PMID: 32758659 DOI: 10.1016/j.cmi.2020.07.024] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 40.5] [Reference Citation Analysis]
104 Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun 2021. [PMID: 34222744 DOI: 10.1002/hep4.1745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
105 Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Reference Citation Analysis]
106 Mani I, Alexopoulou A. Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic. Ann Gastroenterol 2021;34:625-33. [PMID: 34475732 DOI: 10.20524/aog.2021.0628] [Reference Citation Analysis]
107 Levy E, Stintzi A, Cohen A, Desjardins Y, Marette A, Spahis S. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19. Am J Physiol Gastrointest Liver Physiol 2021;321:G99-G112. [PMID: 34009033 DOI: 10.1152/ajpgi.00106.2021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Di Giorgio A, Nicastro E, Arnaboldi S, Montini O, Di Stasio F, D'Antiga L, Gaio P, Fovino LN, Cananzi M, Pinon M, Calvo PL, Camelli V. "Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study". Clin Res Hepatol Gastroenterol 2021;45:101610. [PMID: 33588313 DOI: 10.1016/j.clinre.2020.101610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
109 Pawlowska J, Lebensztejn DM, Jankowska I. Coronavirus Disease 2019-Liver Injury-Literature Review and Guidelines Based on the Recommendations of Hepatological Societies. Pediatr Gastroenterol Hepatol Nutr. 2021;24:119-126. [PMID: 33833967 DOI: 10.5223/pghn.2021.24.2.119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Sweed D, Abdelsameea E, Khalifa EA, Abdallah H, Moaz H, Moaz I, Abdelsattar S, Abdel-Rahman N, Mosbeh A, Elmahdy HA, Sweed E. SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore. Egypt Liver J 2021;11:64. [PMID: 34777871 DOI: 10.1186/s43066-021-00123-6] [Reference Citation Analysis]
111 Li D, Ding X, Xie M, Tian D, Xia L. COVID-19-associated liver injury: from bedside to bench. J Gastroenterol. 2021;56:218-230. [PMID: 33527211 DOI: 10.1007/s00535-021-01760-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
112 Wiśniewska H, Skowron M, Bander D, Hornung M, Jurczyk K, Karpińska E, Laurans Ł, Socha Ł, Czajkowski Z, Wawrzynowicz-Syczewska M. Nosocomial COVID-19 Infection and Severe COVID-19 Pneumonia in Patients Hospitalized for Alcoholic Liver Disease: A Case Report. Am J Case Rep 2020;21:e927452. [PMID: 32973125 DOI: 10.12659/AJCR.927452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
114 Simon TG, Hagström H, Sharma R, Söderling J, Roelstraete B, Larsson E, Ludvigsson JF. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study. BMC Gastroenterol 2021;21:439. [PMID: 34814851 DOI: 10.1186/s12876-021-02017-8] [Reference Citation Analysis]
115 Khan A, Bilal M, Morrow V, Cooper G, Thakkar S, Singh S. Impact of the Coronavirus Disease 2019 Pandemic on Gastrointestinal Procedures and Cancers in the United States: A Multicenter Research Network Study. Gastroenterology 2021;160:2602-2604.e5. [PMID: 33662388 DOI: 10.1053/j.gastro.2021.02.055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
116 Zaky S, Alboraie M, El Badry M, Metwally MA, Abdelaziz A, Fouad Y, Abd-Elsalam S, Mahmoud A, Shiha G, Baki AA, El Kassas M, Esmat G. Management of liver disease patients in different clinical situations during COVID-19 pandemic. Egypt Liver J 2021;11:21. [PMID: 34777868 DOI: 10.1186/s43066-021-00091-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
117 Chen J, Hall S, Vitetta L. Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Rev Med Virol 2021;31:1-13. [PMID: 34546607 DOI: 10.1002/rmv.2211] [Cited by in Crossref: 8] [Article Influence: 8.0] [Reference Citation Analysis]
118 Kim D, Bonham CA, Konyn P, Cholankeril G, Ahmed A. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00723-0. [PMID: 34256143 DOI: 10.1016/j.cgh.2021.07.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]